The global Alcohol Use Disorder Treatment market garnered a market value of USD 700 million in 2023 and is expected to accumulate a market value of USD 1,300 million by registering a CAGR of 6.4% in the forecast period 2023 to 2033.
The rising incidence of alcohol abuse and binge drinking is predicted to fuel the industry. This disease makes no distinctions and may affect anybody, regardless of age or gender, creating a larger market for alcohol use disorder treatment.
Alcohol use disorder (AUD) is a common, chronic, relapsing illness defined by a reduced capacity to cease or regulate alcohol consumption in the face of considerable impairment, distress, or other negative effects. It is one of the most frequent drug use diseases in the world, affecting millions of people. Its clinical presentation variety reflects a complex interplay between numerous environmental, physiological, psychological, social, and biological elements that result in illness development and progression.
It is a very diverse disorder with complicated biology that affects people physically, emotionally, and socially. It is governed by multiple genes and gene-by-environment interactions, with a strong genetic effect predisposing certain people to acquire AUD. It is a prominent public health problem that causes enormous social impact and has a high morbidity and death rate.
According to the WHO, about one-third of Americans consume enough alcohol to be classified at risk for alcohol addiction, and around three million fatalities, or 5.3% of all deaths, are recorded each year from alcohol consumption. On the plus side, there are several options for AUD treatment.
Hence, the growing incidence of addiction in the population, an expanding medicinal product pipeline, and the active participation of generic manufacturers in providing cheaper pharmaceuticals are the primary factors predicted to fuel the growth of the worldwide alcohol use disorder treatment market throughout the forecast period.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value (2023) | USD 700 million |
| Anticipated Forecast Value (2033) | USD 1,300 million |
| Projected Growth Rate (2023 to 2033) | 6.4% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for alcohol use disorder treatment is projected to increase at a CAGR of 6.4% during the forecast period between 2023 and 2033, reaching a total of USD 1,300 million in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 5.5%.
The increased need for alcohol use disorder treatment is mostly due to the disease's global prevalence, with high prevalence observed in Eastern European nations, sections of South East Asia, and selected American countries. According to the Institute of Medicine, the prevalence of Fetal Alcohol Syndrome (FAS) in the USA in 1996 was between 0.5 and 3.0 instances per 1,000.
According to recent research from various US sites, the incidence of FAS was determined to be 2 to 7 instances per 1,000, with the prevalence of Fetal Alcohol Spectrum Disorders (FASD) estimated to be 20 to 50 cases per 1,000. Owing to the growing number of fatalities from alcohol-related liver illness is propelling market expansion throughout the assessment period.
Growing Alcohol Abuse to Improve Maintenance and Performance
Over the last two decades, worldwide alcohol use disorder treatment has climbed threefold. Alcohol abuse is one of the significant risk factors for population health across the world.
According to the World Health Organization, excessive alcohol consumption accounts for 5.1% of the worldwide illness burden, with males accounting for 7.1% and females accounting for 2.2%. The worldwide treatment market is expected to generate considerable revenue over the projected period, owing to these factors.
Expanding the Number of Rehabilitation Centres to Drive the Market over the Assessment Period
Rising awareness regarding alcohol use disorder and an expanding number of rehabilitation centers are likely to drive market expansion in the approaching years. The worldwide market for alcohol use disorder treatment is expanding at an alarming rate. The rising usage of prescription pharmaceuticals is also considered contributing to the market's rise.
Increased government support, such as an increase in initiatives to improve consumer awareness about drug addiction is likely to drive this market throughout the forecast period. The continual development of novel therapies and pharmaceuticals for alcohol use disorder treatment is also expected to enhance this market throughout the forecast period.
Principal Consultant
Reduced Knowledge of Viable Pharmacological Therapy to Stifle Market Growth
The core reason for AUD globally is a lack of resilience to overcome addiction, which leads to inconsistencies in treatment. Reduced knowledge of viable pharmacological therapy for AUD, particularly in emerging and underdeveloped nations, is a prominent factor limiting market expansion.
The availability of low-cost alternatives such as psychotherapy, counselling, and classic cold-turkey AUD therapies also has an impact on the rapid expansion. Alcohol abusers in India generally favour cultural de-addiction techniques such as Ayurveda and homoeopathy.
Thus, the availability of numerous replacements for alcohol use disorder treatment is a key factor stifling market expansion. A lack of knowledge of alcohol dependency as a curable condition may limit the market for alcohol use disorder treatment.
Governments Initiatives to Widen Profit Margins
Asia Pacific is predicted to develop at the fastest rate during the forecast period. This is due to the fact that the governments of these regions are undertaking a number of programs to tackle drug addiction.
Owing to the large populations in countries such as China and India, Asia-Pacific is expected to be the fastest-expanding alcohol use disorder treatment market. As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6% during the forecast period 2023 to 2033.
Soaring Number of Alcohol Drinkers to Accelerate Market Growth
North America had the largest share of the global alcohol use disorder treatment market in 2021. This is because the number of alcohol drinkers in the United States has increased and this disease makes no distinctions and may affect anybody, irrespective of age or gender, creating a larger market for alcohol use disorder treatment.
Rising usage of addiction treatment options, particularly for AUD, and a well-established healthcare infrastructure are likely to boost market possibilities. Combining alcohol with drugs leads to alcohol dependency, increasing the demand for AUD treatment. North America is expected to grow at a CAGR of 6.2% during the forecast period 2023 to 2033.
Burgeoning Rates of Alcohol Abuse fuelling the Growth of the Market
Europe dominates the alcohol use disorder treatment market owing to burgeoning rates of alcohol abuse, particularly in the United Kingdom. According to the World Health Organization (WHO), liver cirrhosis accounts for around 2% of all fatalities in European nations, whereas alcohol use accounts for approximately 1.5% of all deaths in England and Wales, according to figures released by the Office of National Statistics, United Kingdom Alcohol intake is also the leading cause of liver disease globally. Thus, owing to the aforementioned reasons, Europe is expected to grow at a CAGR of 6.3% during the forecast period 2023 to 2033.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Multidisciplinary Treatment Segment to enhance Sales Prospects
Addiction is a rising problem in today's culture, with over twenty million Americans suffering from at least one addiction. Understanding addiction allows people to better understand themselves and make more educated decisions about their health and well-being. Alcohol is among the most overused drugs in the world, with over 300 million people suffering from the illness, which has a negative impact on their overall health and well-being.
The use of multidisciplinary treatment in addiction tries to analyze mind functioning and optimize brain problems in order for people to operate better. This has made addiction therapy more comprehensive and dependable, with many strategies used. Various research demonstrating the benefits of these strategies in the treatment of addiction has rendered these therapies safe to employ.
Multidisciplinary addiction treatment attempts to have long-term and sustained benefits for those suffering from addiction. These therapies recognize the importance of personality in affecting everyday human interactions such as feelings, ideas, and sensations. Multidisciplinary treatment differs based on the individual and any influencing variables. Individuals suffering from mental illnesses, for example, respond differently to therapies.
The complex approach required by the addiction dynamic necessitates the use of multidisciplinary treatment. Hence, the multidisciplinary treatment segment is likely to be the most preferred treatment type, accelerating the growth of the alcohol use disorder treatment market.
The Alcohol Abuse Segment to be Most Lucrative Disorder Type
Due to the changing lifestyles, more disposable money, and a larger young population in India, alcohol abuse is on the rise in emerging countries.
Alcohol is also a risk factor for mouth, throat, liver, and colon cancer. These will be the primary driving forces in the global alcohol use disorder treatment market.
Key start-up players in the alcohol use disorder treatment are offering new and innovative product lines to consolidate their market presence, these aforementioned start-ups have left no stone unturned. Some specific instances of key alcohol use disorder treatment start-ups are as follows:
Key players in the alcohol use disorder treatment market are Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX THERAPEUTICS, Kinnov Therapeutics, Opiant Pharmaceuticals, Omeros Corporation, GlaxoSmithKline plc and Merck & Co. Inc.
Recent Developments:
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 700 million |
| Market Value in 2033 | USD 1,300 million |
| Growth Rate | CAGR of 6.4% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Disorder Type, Treatment Type, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, India, Singapore, Thailand, Indonesia, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Companies Profiled | Alkermes Plc.; Teva Pharmaceutical Industries Ltd.; BioCorRx, Inc.; Adial Pharmaceuticals Inc.; Addex Therapeutics Ltd.; Kinnov Therapeutics; Opiant Pharmaceuticals; Omeros Corporation; GlaxoSmithKline plc; Merck & Co. Inc. |
| Customization | Available Upon Request |
The United States may witness significant growth in the alcohol use disorder treatment market.
The increasing awareness about the harmful effects of alcohol abuse and the rising demand for evidence-based treatment options are expected to drive alcohol use disorder treatment sales.
The increasing adoption of telemedicine and the development of new and innovative treatment options are some of the key trends driving the alcohol use disorder treatment market.
The market recorded a CAGR of 5.5% in 2022.
Substantial investment in research and development, the development of new and innovative treatment options, and the expansion into new markets may provide growth prospects for the market players.
1. Executive Summary | Alcohol Use Disorder Treatment Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disorder Type 5.1. Alcohol Abuse 5.2. Alcohol Dependence 5.3. Alcohol Addiction 5.4. Alcoholism 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type 6.1. Medication 6.2. Therapy 6.3. Multidisciplinary Treatment 6.4. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. Asia Pacific 7.5. Middle East & Africa (MEA) 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Key Countries Market Analysis 14. Market Structure Analysis 15. Competition Analysis 15.1. Alkermes 15.2. Teva Pharmaceutical Industries Ltd. 15.3. BioCorRx, Inc. 15.4. Adial Pharmaceuticals 15.5. ADDEX THERAPEUTICS 15.6. Kinnov Therapeutics 15.7. Opiant Pharmaceuticals 15.8. Omeros Corporation 15.9. GlaxoSmithKline plc 15.10. Merck & Co. Inc. 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Alcohol Use Disorder Treatment Market
